Tag: Hemophilia

Hemophilia A and B Market Expected to Grow $9.3bn by 2028

The hemophilia A and B market is expected to grow from $7.0bn in 2018 to $9.3bn by 2028 across the eight major markets (8MM*) at a compound annual growth rate (CAGR) of 2.9%, according to GlobalData, ...

Pfizer Announced Updated Results from Study Evaluating SB-525 Gene Therapy for Hemophilia A

Sangamo Therapeutics, Inc., a genomic medicine company, and Pfizer, Inc. announced updated results from the Phase 1/2 Alta study evaluating investigational SB-525 gene therapy for severe hemophilia A....

Takeda Announced Updated Results from its Phase IIIb/IV Clinical Trial for ADYNOVATE®

takeda
Takeda Pharmaceutical Company Limited, R&D-driven, global biopharmaceutical company with a leadership position in rare diseases, has announced updated results from its phase IIIb/IV clinical trial...

Bayer Announced Partnership with the WHF Humanitarian Aid Program

Bayer announced a five-year partnership with the World Federation of Hemophilia (WFH) Humanitarian Aid Program. The Program will bring treatments to patients in more than 60 countries where access to ...

Support of Haemophilia Parients in Azerbaijan

Haemophilia patients are covered by Azerbaijan government not only through providing free of charge medicines but also being supported to have healthy and high quality of life. This topic was highl...

Hemophilia Market Size Worth $16.9 Billion By 2026

The global hemophilia market is expected to reach USD 16.9 billion by 2026 Increasing need for diagnosis of the target population in order to initiate prophylaxis treatment and supportive government p...